Jushi Holdings (JUSHF) Cash from Financing Activities (2021 - 2026)

Jushi Holdings (JUSHF) reported Cash from Financing Activities of $11.1 million for Q1 2026, up 228.4% year-over-year from $3.4 million in Q1 2025, and up 540.69% quarter-over-quarter from -$2.5 million in Q4 2025.

Jushi Holdings (JUSHF) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Cash from Financing Activities data on file, last reported at $11.1 million in Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at $11.1 million, up 228.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.5 million (up 158.31% YoY), and the FY2025 annual result was $767000.0, up 103.14% from the prior year.
  • Cash from Financing Activities advanced to $11.1 million in Q1 2026 per JUSHF's latest filing, from -$2.5 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $20.1 million in Q2 2023 and troughed at -$13.7 million in Q3 2024.
  • A 5-year average of $2.1 million and a median of -$262000.0 in 2025 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2023 and 2026: Cash from Financing Activities sank 4971.21% in 2023, then surged 228.4% in 2026.
  • A 5-year view of Cash from Financing Activities shows it stood at -$2.1 million in 2022, then plunged by 59.51% to -$3.3 million in 2023, then jumped by 56.86% to -$1.4 million in 2024, then tumbled by 74.91% to -$2.5 million in 2025, then soared by 540.69% to $11.1 million in 2026.
  • Business Quant data shows JUSHF's Cash from Financing Activities at $11.1 million in Q1 2026, -$2.5 million in Q4 2025, and $166000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Jushi Holdings - - 29.88 Mn 11.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.12 Mn
Mar 31, 2026 11.12 Mn
Dec 31, 2025 -2.52 Mn
Dec 31, 2025 -2.52 Mn
Sep 30, 2025 166,000.00
Sep 30, 2025 166,000.00
Jun 30, 2025 -262,000.00
Jun 30, 2025 -262,000.00
Mar 31, 2025 3.39 Mn
Mar 31, 2025 3.39 Mn
Dec 31, 2024 -1.44 Mn
Dec 31, 2024 -1.44 Mn
Sep 30, 2024 -13.74 Mn
Sep 30, 2024 -13.74 Mn
Jun 30, 2024 -2.78 Mn
Jun 30, 2024 -2.78 Mn
Mar 31, 2024 -6.49 Mn
Mar 31, 2024 -6.49 Mn
Dec 31, 2023 -3.35 Mn
Dec 31, 2023 -3.35 Mn